To directly test the hypothesis that type I IFN plays a significant role in the development of obesity and type 2 diabetes-related metabolic abnormalities, we exposed mice lacking the receptor for IFN-α (IFNAR−/−) to an HFD. Here, IFNA1 is linked to obesity disorder.